Ahmed Hamdy

About Ahmed Hamdy

Member of the executive Management team and Head of Clinical Development, Clinical Operations, Biostats and Data Management teams• Grew Acerta Pharma from 5 employee to 60 employees• Acquired two compounds from big Pharma• Raised substantial funds from investor Communities • Collaborate in developing strategies and solving problems across diverse functional areas of the business, clinical medicine, clinical operations, biostatistics, data management, regulatory affairs, and marketing. • Responsible for clinical time-lines of decisions which may have a long-term impact on the company’s success. • Responsible for negotiating important and difficult policy-making matters with internal and external executive-level management • 19 years of hands on clinical research experience in academia and pharmaceutical clinical development.(12 in industry pharmaceutical and biotech development and 7 academic)• Extensive pharmaceutical industry experience in planning, designing and executing Phase I clinical trials in Oncology, Urology, Gastroentrology, Cardiovascular and Pain therapeutic areas with increasing responsibilities. • Proven success working with cross-functional teams to successfully execute phase I clinical studies• Participated in multiple regulatory meetings and interactions and authored responses to regulatory agencies.• Participated in multiple successful NDA/aNDA submissions • Unique understanding of commercial needs relevant to drug development and product differentiation• Proven track record of developing and deploying high performance teams in Clinical Development.• Significant experience in busy and demanding leadership roles• Member of multiple due diligence teams evaluating early, and mid stage development opportunities considered by Business Development and Scientific Licensing groups• Academic and clinical experience in US and EgyptSpecialties: Executive Biotech/pharmaceutical industry experience in planning, designing and executing Phase I -IVclinical trials in Oncology, Urology, Gastroentrology, Cardiovascular, Autoimmune and Pain therapeutic areas with increasing responsibilities.

Experience

1. Chief Medical Officer

   Curis

   May 2025 — Present

Education

• University of Colorado Anschutz

  Experimental Pathology

  1993 — 1997

• Cairo University

  M.B.B.CH, Medcine

  1982 — 1989